Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients

BACKGROUND: Guideline-based best practice treatment for muscle invasive bladder cancer (MIBC) involves neoadjuvant chemotherapy followed by radical cystectomy (NACRC). Prior studies have shown that a minority of patients receive NACRC and older age and renal function are drivers of non-receipt of NA...

Descripción completa

Detalles Bibliográficos
Autores principales: Au, Daniel, Lee, Eugene K., Popoola, Taiye O., Parker, William P., Onge, Jarron M. Saint, Ellis, Shellie D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321501/
https://www.ncbi.nlm.nih.gov/pubmed/33848073
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.0594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321501/
https://www.ncbi.nlm.nih.gov/pubmed/33848073
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.0594

Ejemplares similares